Treatment Patterns and Asthma Control Among US Allergy and Pulmonary Community Practices: Results of the CHARIOT Study
Philip Marcus(St. Francis Hospital), Don A. Bukstein(Institute for Asthma and Allergy), Robert D. Arnold(Auburn University), Sean Ekins(Collaborative Drug Discovery (United States)), Patricia Sacco(Novartis (United States)), Marc Massanari(Novartis (United States)), James F. Donohue(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
<i>In silico</i> pharmacology for drug discovery: methods for virtual ligand screening and profiling
|British Journal of Pharmacology|2007|693
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
|Molecular Pharmacology|2007|146
CATMoS: Collaborative Acute Toxicity Modeling Suite
|Environmental Health Perspectives|2021|145
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119